This is a non-core endpoint: only basic statistics are computed.
Benign neoplasm: Vulva
CD2_BENIGN_VAGINA_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleonly females |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpointsNone |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D28
- Name in latin
- Neoplasma benignum vulvae
Similar endpoints
↥List of similar endpoints to
Benign neoplasm: Vulva
based on the number of shared cases.
Similar with more cases:
- Benign neoplasm: Vulva
- Benign neoplasm of other and unspecified female genital organs
- Benign neoplasm of other and unspecified female genital organs
- Benign neoplasms
- Benign neoplasms
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 754 | 754 | - |
| Unadjusted period prevalence (%) | 0.26 | 0.26 | - |
| Median age at first event (years) | 41.68 | 41.68 | - |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 678
- Matched controls
- 6779
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D28.0
ICD-10 Finland
Benign neoplasm: Vulva
11666.0
323.0
457
*
LFB10
NOMESCO Finland
Excision of lesion of vulva or perineum
91.6
162.5
177
26
22120
ICD-8 Finland
Benign neoplasm of other female genital organs, Vulva
+∞
131.7
122
*
PJA12
NOMESCO Finland
Sentinel node biopsy
679.0
63.9
62
*
115
Kela drug reimbursment
Breast cancer
+∞
59.2
56
*
22121
ICD-8 Finland
NA
+∞
51.7
49
*
22122
ICD-8 Finland
NA
+∞
50.7
48
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
46.4
44
*
HAB40
NOMESCO Finland
Wedge excision of mammary gland
50.8
36.1
43
9
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
33.6
32
*
LFB20
NOMESCO Finland
Destruction of lesion of vulva or perineum
37.2
33.2
42
12
LFB00
NOMESCO Finland
Biopsy of vulva or perineum
8.4
30.8
70
92
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
30.4
29
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
27.3
26
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
54.0
26.4
31
6
H02AB02
ATC
dexamethasone; systemic
13.8
25.5
44
34
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
135.0
24.8
26
*
130
Kela drug reimbursment
Malignant tumour
+∞
24.1
23
*
L02BG04
ATC
letrozole; oral
12.7
24.1
43
36
A04AA02
ATC
granisetron; systemic, transdermal
237.7
22.8
23
*
HAC20
NOMESCO Finland
Total mastectomy
124.2
22.7
24
*
L02BA01
ATC
tamoxifen; oral
56.7
19.0
22
*
C50.99
ICD-10 Finland
Breast, unspecified
+∞
18.8
18
*
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
+∞
17.8
17
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
184.6
17.6
18
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
16.7
16
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
16.7
16
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
16.7
16
*
L02BG03
ATC
anastrozole; oral
+∞
15.7
15
*
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
+∞
15.7
15
*
C50
ICD-10 Finland
Malignant neoplasm of breast
87.1
15.6
17
*
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
4.9
13.8
45
97
Z09.0
ICD-10 Finland
Follow-up examination after surgery for other conditions
2.6
13.2
101
425
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
+∞
12.5
12
*
C50.42
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor
+∞
12.5
12
*
THW99
NOMESCO Finland
Other minor procedure in surgery of mammary gland
66.1
11.6
13
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
11.5
11
*
8500/3-C50.4
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast
+∞
11.5
11
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
11.5
11
*
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
+∞
11.5
11
*
HAB50
NOMESCO Finland
Partial excision of mammary gland with reconstructive operation
+∞
11.5
11
*
C50.91
ICD-10 Finland
Malignant tumor in another specified localization in ductal mammary gland
+∞
10.4
10
*
C50.81
ICD-10 Finland
Overall malignant tumor of the mammary gland, ductal tumor
+∞
10.4
10
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
+∞
10.4
10
*
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
+∞
10.4
10
*
HA1AA
NOMESCO Finland
X-ray mammography
3.6
10.2
45
131
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
2.3
10.1
102
492
HAB99
NOMESCO Finland
Other partial excision of mammary gland
9.7
9.8
19
20
J01DA01
ATC
[U] cefalexin; systemic
1.7
9.7
438
3519
A03FA01
ATC
metoclopramide; systemic, rectal
2.1
9.7
114
590
L03AA13
ATC
pegfilgrastim; parenteral
101.4
9.4
10
*
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
+∞
9.4
9
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
9.4
9
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.8
9.4
187
1175
HA4AT
NOMESCO Finland
Labeling mammary gland pathology with ultrasound guidance
13.9
9.2
15
11
N75.0
ICD-10 Finland
Cyst of Bartholin gland
7.1
8.6
20
29
XX3DW
NOMESCO Finland
Time consuming IT work
3.3
8.5
42
134
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
91.2
8.4
9
*
C50.49
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology
+∞
8.3
8
*
C50.51
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor
+∞
8.3
8
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
8.3
8
*
A02BC02
ATC
pantoprazole; systemic
1.6
8.3
437
3578
JN4BD
NOMESCO Finland
Extensive body CT
3.3
8.1
39
122
HA6AA
NOMESCO Finland
Extra corporeal mammography of operated mammary gland
10.2
8.1
15
15
LFC00
NOMESCO Finland
Partial excision of vulva
22.3
8.0
11
5
S18
ICPC
Laceration/cut
1.6
7.9
263
1904
8473
FHL
Guinea pig or gland excision
9.6
7.8
15
16
J01AA02
ATC
doxycycline; systemic
1.7
7.5
539
4718
ULA02
NOMESCO Finland
Kolposcopy
2.0
7.5
91
478
8500/2-C50.9
ICD-O-3
Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS
+∞
7.3
7
*
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
7.3
7
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
7.3
7
*
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
+∞
7.3
7
*
HA013
NOMESCO Finland
Radiotherapy after total ablation of mammary gland
+∞
7.3
7
*
A79
ICPC
Malignancy NOS
+∞
7.3
7
*
8260/3-C73.9
ICD-O-3
Papillary adenocarcinoma, NOS, of thyroid gland
+∞
7.3
7
*
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.6
7.0
250
1829
R01AD09
ATC
mometasone; nasal
1.5
7.0
325
2533
A02BC05
ATC
esomeprazole; systemic
1.6
7.0
289
2194
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.6
6.9
240
1743
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.8
6.9
125
756
R03AC02
ATC
salbutamol; inhalant
1.5
6.8
368
2964
LFW96
NOMESCO Finland
Other operation on vulva or perineum
40.5
6.8
8
*
X76
ICPC
Malignant neoplasm breast female
40.5
6.8
8
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.6
6.8
192
1324
J02AC01
ATC
fluconazole; systemic
1.5
6.6
336
2663
C50.11
ICD-10 Finland
Malignant tumor of the central part of the mammary gland,ductal tumor
70.5
6.4
7
*
N90.7
ICD-10 Finland
Vulvar cyst
9.4
6.3
12
13
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.5
6.3
243
1802
C50.31
ICD-10 Finland
Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor
+∞
6.3
6
*
HA1BG
NOMESCO Finland
MRI examination of mammary gland with high intensity magnet
+∞
6.3
6
*
8520/3-C50.9
ICD-O-3
Lobular carcinoma, NOS, of breast, NOS
+∞
6.3
6
*
L01BC06
ATC
capecitabine; oral
+∞
6.3
6
*
C50.4
ICD-10 Finland
Malignant neoplasm: Upper-outer quadrant of breast
+∞
6.3
6
*
A04AD12
ATC
aprepitant; systemic
+∞
6.3
6
*
Z51.5
ICD-10 Finland
Palliative care
5.8
6.2
16
28
62212
ICD-8 Finland
Infective diseases of uterus (except cervix), vagina and vulva, Bartholinitis acuta
10.1
6.0
11
11
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
77
327
2.51
11.77
3.7
1.5
3.0
3.2
ug/l
0.15
64
247
388
2928
1.67
10.71
5.1
3.5
10.6
10.5
umol/l
0.05
363
2736
565
4768
1.74
9.67
7.2
5.3
78.7
74.8
u/l
1.22
529
4406
360
2736
1.60
9.15
5.2
4.5
1.2
1.2
mmol/l
0.62
318
2425
200
1323
1.70
8.76
2.5
1.9
—
—
—
0
0
385
3043
1.54
7.80
6.7
5.0
1.2
1.2
mmol/l
0.14
319
2593
353
2742
1.54
7.71
3.8
3.5
—
—
—
0
0
480
4002
1.55
7.47
3.4
2.9
48.6
38.3
u/l
1.15
446
3694
137
856
1.73
7.27
5.0
4.7
32.8
33.9
%
0.58
107
557
411
3416
1.45
5.79
8.2
6.6
4.2
4.1
e9/l
0.49
360
2934
250
1938
1.43
4.94
2.5
2.2
55.0
57.9
u/l
0.60
232
1768
557
4977
1.46
4.83
4.4
4.4
12.7
12.0
mm/h
0.64
514
4612
309
2517
1.39
4.49
4.9
3.5
35.6
36.1
g/l
0.90
284
2317
411
3523
1.37
4.28
3.9
3.9
6.8
6.6
mmol/l
0.59
382
3228
71
430
1.72
4.20
2.3
2.1
0.2
0.2
g/l
0.86
65
404
92
597
1.62
4.19
2.0
2.1
7.0
5.8
umol/l
0.24
82
508
40
206
1.99
3.94
2.2
2.1
2877.3
2631.9
u/l
0.03
14
88
257
2089
1.35
3.61
3.3
2.0
2.4
2.4
mmol/l
0.37
205
1769
705
6724
1.75
3.57
16.1
13.3
3.9
3.9
mmol/l
0.26
688
6511
681
6451
1.57
3.39
14.5
11.4
18.5
19.6
mg/l
0.48
552
4886
160
1217
1.40
3.37
1.7
1.7
1273.0
1210.7
nmol/l
0.27
117
903
487
4366
1.33
3.35
5.3
4.8
1478.2
4252.3
e6/l
—
6
58
702
6708
1.67
3.25
16.0
13.2
139.7
139.8
mmol/l
0.47
687
6509
201
1597
1.35
3.23
1.5
1.4
—
—
—
0
0
14
49
2.89
3.20
1.6
1.3
—
—
—
0
0
192
1527
1.35
3.04
2.4
2.1
9626.0
4894.9
umol/l
0.49
168
1296
87
604
1.50
2.97
2.1
1.9
367.1
365.2
nmol/l
0.03
75
540
18
76
2.40
2.91
1.3
1.2
—
—
—
0
0
18
77
2.37
2.83
1.3
1.2
—
—
—
0
0
652
6165
1.43
2.82
12.7
10.3
80.1
79.8
ml/min/173m2
0.14
548
4893
233
1926
1.30
2.79
2.8
2.5
26.6
28.8
u/l
1.14
220
1842
113
836
1.41
2.78
3.3
2.3
0.8
0.8
mmol/l
0.00
94
768
18
78
2.34
2.76
1.3
1.2
—
—
—
0
0
22
106
2.11
2.65
1.3
1.3
—
—
—
0
0
14
55
2.57
2.62
1.5
1.3
—
—
—
0
0
58
379
1.57
2.62
1.4
1.6
—
—
—
0
0
16
68
2.38
2.57
1.5
1.4
—
—
—
0
0
18
81
2.25
2.55
1.3
1.2
—
—
—
0
0
18
81
2.25
2.55
1.3
1.2
—
—
—
0
0
5
7
7.18
2.55
1.6
1.1
—
—
—
0
0
33
187
1.80
2.53
2.5
3.3
24.9
24.9
mmol/l
0.01
27
173
18
82
2.22
2.49
1.3
1.2
—
—
—
0
0
167
1342
1.31
2.43
1.3
1.3
15.1
38.6
iu/ml
6.15
49
441
345
3034
1.25
2.43
2.4
2.3
80.4
80.0
nmol/l
0.08
291
2701
10
34
2.97
2.42
2.2
1.3
—
—
—
0
0
317
2771
1.25
2.33
2.1
2.0
103.1
99.3
pmol/l
0.54
145
1273
71
500
1.46
2.30
3.4
3.3
244.6
229.3
u/l
0.65
63
469
77
551
1.44
2.29
3.1
3.2
109.1
79.6
ng/l
1.25
62
477
6
13
4.64
2.27
3.7
1.2
97.0
86.0
ng/l
—
6
13
15
66
2.30
2.25
2.3
1.3
—
—
—
0
0
714
6919
1.60
2.24
11.2
9.0
23.3
23.1
u/l
0.08
687
6635
9
29
3.13
2.23
1.0
1.6
—
—
—
0
0
14
60
2.36
2.23
1.6
1.3
—
—
—
0
0
5
9
5.58
2.21
1.0
1.0
—
—
—
0
0
12
48
2.52
2.19
1.6
1.3
—
—
—
0
0
92
694
1.37
2.05
6.4
4.0
1.1
1.0
mmol/l
0.60
83
627
18
90
2.02
2.02
2.2
1.4
—
—
—
0
0
44
289
1.55
2.00
2.9
3.1
1.3
2.0
mmol/l
0.55
34
213
234
2009
1.24
1.96
1.8
2.1
118.9
154.9
u/l
1.63
216
1892
19
99
1.94
1.91
1.3
1.2
—
—
—
0
0
159
1312
1.27
1.88
1.3
1.3
6.5
11.9
u/ml
0.77
59
506
266
2326
1.22
1.86
3.3
3.5
24.7
41.6
ng/l
0.50
156
1495
18
94
1.94
1.81
2.2
1.4
—
—
—
0
0
93
718
1.34
1.80
20.1
23.4
1.2
1.3
inr
0.07
13
106
49
339
1.48
1.78
1.4
1.5
—
—
—
0
0
589
5592
1.24
1.70
5.0
4.5
14.6
14.8
pmol/l
1.26
535
5129
19
104
1.85
1.68
1.4
1.2
0.6
0.6
nmol/l
0.08
19
98
12
55
2.20
1.68
2.8
1.7
38.5
77.7
u/ml
0.20
12
50
8
31
2.60
1.66
2.5
1.1
—
—
—
0
0
8
31
2.60
1.66
2.5
1.1
—
—
—
0
0
8
31
2.60
1.66
2.5
1.1
—
—
—
0
0
29
181
1.63
1.65
1.8
1.7
6.9
1.4
ug/l
0.68
24
157
7
25
2.82
1.65
1.6
1.8
6.5
4.5
mg/l
—
7
25
10
43
2.34
1.61
2.2
1.2
—
—
—
0
0
8
32
2.52
1.60
1.0
1.0
—
—
—
0
0
184
1576
1.22
1.55
2.3
2.2
2.9
2.9
mg/l
0.04
160
1338
8
33
2.44
1.54
2.3
1.5
—
—
—
0
0
204
1767
1.21
1.54
2.4
2.8
1129.5
1085.2
ng/l
0.05
165
1480
11
51
2.17
1.51
1.4
1.1
—
—
—
0
0
6
21
2.87
1.51
1.5
1.1
—
—
—
0
0
6
21
2.87
1.51
1.5
1.1
—
—
—
0
0
32
211
1.54
1.48
1.9
1.8
—
—
—
0
0
7
28
2.51
1.45
1.7
2.0
33.9
41.8
ug/l
—
7
28
109
889
1.26
1.43
2.8
2.3
12.7
13.4
umol/l
0.45
104
816
90
717
1.29
1.43
2.5
2.4
20.9
22.8
%
0.68
72
610
99
801
1.27
1.39
2.7
2.3
2.4
2.4
g/l
0.26
93
745
182
1574
1.21
1.39
1.3
1.3
0.5
2.0
u/ml
3.56
49
396
22
135
1.65
1.37
1.4
1.2
—
—
—
0
0
17
97
1.77
1.36
1.4
1.8
—
—
—
0
0
659
6377
1.27
1.35
6.0
5.4
1.8
2.1
mu/l
0.75
609
5865
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
20
120
1.68
1.35
2.2
3.0
0.4
0.4
u/ml
0.05
12
78
167
1437
1.21
1.34
1.8
1.7
0.9
1.1
mg/l
0.32
124
1072
181
1573
1.20
1.31
2.9
3.0
0.3
0.4
e6/l
0.43
129
1171
6
24
2.51
1.30
1.5
1.1
—
—
—
0
0
6
24
2.51
1.30
1.5
1.1
—
—
—
0
0
30
202
1.51
1.29
1.7
1.7
—
—
—
0
0
9
45
2.01
1.23
2.1
1.9
—
—
—
0
0
225
2007
1.17
1.20
3.3
3.0
6.1
6.4
mmol/l
0.46
182
1697
67
531
1.29
1.14
2.1
2.0
33.9
36.2
u/l
0.17
55
447
731
7201
1.50
1.10
22.3
17.4
131.7
132.7
g/l
1.48
725
7083
5
21
2.39
1.09
1.2
1.1
—
—
—
0
0
5
22
2.28
1.03
1.6
1.2
—
—
—
0
0
5
22
2.28
1.03
1.6
1.2
—
—
—
0
0
321
2973
1.14
1.00
3.2
2.8
81.5
85.9
ug/l
0.32
293
2742
21
140
1.51
0.98
1.3
1.7
—
—
—
0
0
131
1499
0.85
0.96
4.2
4.3
1.0
1.0
kg/l
0.25
17
233
100
851
1.20
0.93
2.1
1.7
—
—
—
0
0
41
314
1.32
0.92
1.5
1.7
—
—
—
0
0
6
28
2.15
0.91
1.0
1.3
—
—
—
0
0
49
387
1.28
0.89
1.4
1.7
—
—
—
0
0
22
152
1.46
0.89
1.6
1.7
4759.3
11930.6
e6/l
1.08
12
110
16
103
1.57
0.88
1.4
1.3
—
—
—
0
0
6
30
2.01
0.87
1.0
1.1
48.3
51.6
u/l
—
6
23
220
2006
1.14
0.85
4.0
3.8
15.9
7.3
mg/mmol
0.95
126
1134
428
4063
1.12
0.85
3.2
3.0
—
—
—
0
0
10
57
1.76
0.84
1.3
1.1
—
—
—
0
0
10
57
1.76
0.84
1.3
1.1
—
—
—
0
0
10
57
1.76
0.84
2.6
1.4
—
—
—
0
0
8
46
1.75
0.82
1.4
1.3
1.1
1.7
nmol/l
—
8
39
16
105
1.54
0.82
1.0
1.1
—
16.9
—
0
7
10
58
1.73
0.80
1.3
1.1
—
—
—
0
0
10
58
1.73
0.80
1.3
1.1
—
—
—
0
0
10
58
1.73
0.80
1.3
1.1
—
—
—
0
0
0
24
0.00
0.79
0.0
1.1
—
—
—
0
0
0
24
0.00
0.79
0.0
1.3
—
—
—
0
0
0
25
0.00
0.79
0.0
1.2
—
—
—
0
0
15
98
1.54
0.79
1.3
1.1
5.3
1.9
u/ml
—
7
34
39
493
0.78
0.78
2.6
2.1
46.6
67.8
ml/min/173m2
2.36
12
201
0
28
0.00
0.76
0.0
1.1
—
—
—
0
0
17
116
1.48
0.74
2.2
2.7
—
—
—
0
0
9
55
1.64
0.73
1.0
1.0
—
—
—
0
0
5
25
2.01
0.72
1.4
1.2
14.9
13.9
pmol/l
—
5
20
46
374
1.24
0.69
1.0
1.1
—
—
—
0
0
11
69
1.60
0.68
2.0
1.3
—
—
—
0
0
5
27
1.86
0.68
1.6
1.2
—
—
—
0
0
5
27
1.86
0.68
1.0
1.1
—
—
—
0
0
132
1185
1.14
0.66
3.1
2.1
2.5
2.4
mmol/l
0.67
111
1030
99
871
1.16
0.66
2.5
2.7
4.4
4.7
e6/l
0.06
55
431
628
6140
1.14
0.64
5.9
5.7
40.1
39.4
mmol/mol
0.97
575
5688
5
29
1.73
0.64
1.8
2.8
862.0
1064.0
u/ml
—
5
29
37
297
1.26
0.63
1.4
1.6
—
—
—
0
0
135
1221
1.13
0.61
2.5
2.5
5.7
9.0
e6/l
2.30
115
1060
23
174
1.33
0.60
1.3
1.3
—
—
—
0
0
22
166
1.34
0.59
1.4
1.2
—
—
—
0
0
65
559
1.18
0.58
4.6
5.9
1.7
1.3
mmol/l
0.45
53
442
10
150
0.66
0.58
1.9
1.8
—
—
—
0
0
0
23
0.00
0.58
0.0
1.1
—
—
—
0
0
67
579
1.17
0.57
3.5
3.0
—
—
—
0
0
157
1439
1.11
0.57
1.6
1.7
64341544.3
25673849.2
pmol/l
0.25
129
1188
131
1189
1.12
0.56
1.6
1.5
—
—
—
0
0
11
159
0.69
0.54
1.0
1.2
3.8
3.8
mmol/l
0.01
11
149
21
160
1.32
0.54
1.1
1.2
—
—
—
0
0
11
74
1.49
0.53
1.2
1.1
—
—
—
0
0
641
6295
1.12
0.52
4.1
4.0
1.3
1.2
mmol/l
0.53
584
5728
6
40
1.50
0.51
1.0
1.2
—
—
—
0
0
64
560
1.16
0.49
4.8
5.9
12.2
12.0
kpa
0.06
59
540
7
47
1.49
0.47
2.1
1.4
—
—
—
0
0
22
173
1.28
0.47
1.0
1.1
—
—
—
0
0
13
95
1.37
0.44
1.2
1.1
—
—
—
0
0
14
104
1.35
0.43
4.4
2.2
16.7
16.4
%
—
6
49
68
605
1.14
0.42
2.0
1.6
1.5
1.3
%
1.56
57
531
18
228
0.78
0.42
2.3
1.3
—
—
—
0
0
18
228
0.78
0.42
2.3
1.3
3.8
3.8
g/l
0.08
13
170
127
1174
1.10
0.41
3.7
3.7
242.1
355.9
ng/l
0.23
86
864
0
16
0.00
0.41
0.0
3.1
—
6.5
—
0
8
5
34
1.47
0.40
1.2
1.0
—
—
—
0
0
662
6533
1.11
0.39
4.6
4.5
1.6
1.6
mmol/l
0.33
607
6007
5
35
1.43
0.39
2.4
1.4
—
—
—
0
0
17
133
1.28
0.39
2.7
1.9
130.0
130.6
g/l
—
10
95
14
107
1.31
0.37
1.4
1.5
—
—
—
0
0
6
43
1.40
0.35
2.7
1.3
—
—
—
0
0
665
6573
1.10
0.34
4.6
4.6
4.8
4.8
mmol/l
1.02
612
6074
29
247
1.18
0.33
1.3
2.0
—
—
—
0
0
6
46
1.31
0.33
1.2
1.0
—
—
—
0
0
243
2531
0.94
0.32
4.2
4.1
—
—
—
0
0
25
211
1.19
0.32
4.4
4.1
2.0
1.5
%
0.92
25
201
7
53
1.32
0.31
3.0
3.4
—
—
—
0
0
70
640
1.10
0.30
2.0
1.9
—
—
—
0
0
17
207
0.82
0.30
1.5
1.2
157.4
232.6
miu/ml
—
10
101
181
1723
1.07
0.30
4.0
4.3
0.0
0.0
estimate
0.80
72
552
66
602
1.11
0.30
2.0
1.7
—
—
—
0
0
527
5363
0.94
0.30
18.1
13.9
13.8
13.6
%
1.66
515
5211
53
478
1.12
0.29
6.7
2.9
2.3
2.2
mmol/l
0.01
45
386
62
567
1.10
0.27
2.1
1.8
—
—
—
0
0
8
65
1.23
0.27
1.1
1.1
—
2.0
—
0
5
5
74
0.67
0.26
1.0
1.1
—
—
—
0
0
21
245
0.85
0.25
4.1
3.0
62.4
48.4
%
1.61
21
240
18
213
0.84
0.25
2.3
1.4
3.1
3.0
g/l
0.21
13
174
90
842
1.08
0.25
7.3
6.2
—
—
—
0
0
17
142
1.20
0.25
1.4
1.5
—
—
—
0
0
12
96
1.25
0.24
1.6
1.4
—
—
—
0
0
12
96
1.25
0.24
1.6
1.4
—
—
—
0
0
342
3335
1.05
0.24
3.8
3.9
0.0
0.0
estimate
0.80
73
544
62
572
1.09
0.24
1.2
1.2
174.2
146.0
iu/ml
0.24
22
235
102
964
1.07
0.22
2.4
2.5
1.7
1.8
e6/l
0.08
60
529
14
116
1.21
0.22
3.4
3.4
4.6
4.2
e9/l
0.24
14
116
674
6688
1.07
0.22
5.2
5.1
2.8
2.8
mmol/l
0.76
622
6155
46
502
0.91
0.21
2.0
2.4
4.4
6.3
ug/l
0.95
37
442
16
188
0.85
0.21
1.5
1.5
—
—
—
0
0
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
105.1
—
0
10
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
657
6515
1.07
0.21
4.7
4.6
5.9
5.9
mmol/l
0.30
600
5937
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
5
43
1.16
0.21
1.0
1.4
—
—
—
0
0
5
43
1.16
0.21
1.2
1.4
—
—
—
0
0
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
19
164
1.16
0.20
2.0
1.9
96.4
94.5
%
0.15
19
155
338
3307
1.04
0.20
5.2
5.3
0.0
0.0
estimate
0.50
73
553
590
5839
1.05
0.19
16.0
12.9
39.0
39.0
%
0.07
438
4117
14
118
1.19
0.19
3.4
3.6
61.4
58.2
%
0.48
14
118
16
137
1.17
0.19
3.2
4.1
25.7
23.1
mg/l
—
9
87
21
186
1.13
0.17
1.2
1.4
324.6
325.0
ug/g
—
10
106
5
66
0.76
0.17
1.0
1.1
—
—
—
0
0
22
196
1.13
0.16
1.5
1.6
0.6
0.1
iu/ml
—
5
31
8
70
1.14
0.16
1.1
1.1
—
80.9
—
0
10
8
70
1.14
0.16
1.1
1.1
—
73.4
—
0
5
6
76
0.79
0.15
1.0
1.1
—
—
—
0
0
9
80
1.13
0.15
1.0
1.0
—
—
—
0
0
49
459
1.07
0.15
3.1
2.5
1.2
1.2
mmol/l
0.44
42
377
17
192
0.88
0.15
2.1
2.1
—
—
—
0
0
13
112
1.16
0.14
2.2
1.7
—
—
—
0
0
15
170
0.88
0.13
1.0
1.3
439.1
440.2
mg/l
0.01
15
161
8
99
0.81
0.13
1.3
1.4
—
—
—
0
0
21
232
0.90
0.13
1.3
1.7
—
—
—
0
0
184
1887
0.97
0.13
1.6
1.7
1.3
1.3
mmol/l
0.57
164
1608
16
180
0.89
0.13
1.4
1.4
—
—
—
0
0
48
452
1.07
0.13
2.8
1.4
65.3
67.3
g/l
0.74
42
408
33
306
1.08
0.13
1.6
1.5
—
—
—
0
0
16
179
0.89
0.12
1.4
1.4
—
—
—
0
0
63
601
1.05
0.12
2.0
1.7
—
—
—
0
0
16
178
0.90
0.11
1.4
1.4
—
—
—
0
0
16
178
0.90
0.11
1.4
1.4
—
—
—
0
0
17
188
0.90
0.11
1.3
1.4
—
—
—
0
0
156
1523
1.03
0.10
1.6
1.5
23.0
22.7
nmol/l
0.07
122
1279
10
115
0.87
0.10
1.3
1.7
—
—
—
0
0
51
535
0.95
0.10
1.5
1.6
—
—
—
0
0
11
96
1.15
0.10
1.1
1.2
—
—
—
0
0
28
261
1.08
0.10
2.5
2.1
37.4
39.3
u/l
0.19
21
232
5
45
1.11
0.10
1.0
1.0
526.2
382.4
ng/l
—
5
30
5
46
1.09
0.09
1.0
1.0
76.8
61.5
ng/l
—
5
31
5
46
1.09
0.09
1.0
1.0
795.0
676.3
ng/l
—
5
29
23
213
1.08
0.09
2.7
1.9
9.0
5.2
iu/l
—
7
71
5
48
1.04
0.09
2.4
1.1
—
—
—
0
0
11
124
0.89
0.09
1.0
1.2
—
—
—
0
0
8
76
1.05
0.07
3.0
2.2
12.8
13.3
%
—
8
76
35
334
1.05
0.07
4.3
2.6
121.6
127.9
g/l
0.96
35
318
29
303
0.96
0.05
1.4
1.5
—
—
—
0
0
19
200
0.95
0.04
1.5
1.5
—
—
—
0
0
34
329
1.04
0.03
1.4
1.5
—
—
—
0
0
23
221
1.04
0.03
1.0
1.1
—
—
—
0
0
46
468
0.98
0.01
5.7
2.9
4.4
4.5
pmol/l
0.78
41
403
37
363
1.02
0.01
1.4
1.3
—
—
—
0
0
21
204
1.03
0.00
1.5
1.6
—
329.2
—
0
13
22
222
0.99
0.00
1.0
1.1
—
—
—
0
0
10
101
0.99
0.00
1.9
1.6
—
—
—
0
0
328
3279
1.00
0.00
3.8
3.9
0.0
0.0
estimate
0.00
73
548
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
5
49
1.02
0.00
1.2
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
9
97
0.93
0.00
4.6
4.7
360.1
372.2
umol/l
—
9
80
9
93
0.97
0.00
1.2
1.1
—
—
—
0
0
5
51
0.98
0.00
1.8
1.7
1.2
1.0
g/l
—
5
51
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_VAGINA_EXALLC – Benign neoplasm: Vulva
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).